These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3294402)

  • 21. [Progress in chemotherapeutic agents--beta-lactam antibiotics and beta-lactamase inhibitors].
    Uzuka Y; Matsumoto K
    Nihon Rinsho; 1986 Apr; 44(4):824-30. PubMed ID: 3531574
    [No Abstract]   [Full Text] [Related]  

  • 22. Systemic Timentin is superior to oral tinidazole for antibiotic prophylaxis in elective colorectal surgery. University of Melbourne Colorectal Group.
    Dis Colon Rectum; 1987 Oct; 30(10):786-9. PubMed ID: 2888606
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of ticarcillin and ticarcillin/clavulanic acid on the in-vitro activity of human granulocytes against beta-lactamase-producing Klebsiella pneumoniae.
    Cuffini AM; de Renzi G; Tullio V; Paizis G; Carlone NA
    Int J Tissue React; 1995; 17(5-6):199-203. PubMed ID: 8835630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous infusion of ticarcillin-clavulanate for home treatment of serious infections: clinical efficacy, safety, pharmacokinetics and pharmacodynamics.
    Munckhof WJ; Carney J; Neilson G; Neilson J; Carroll J; McWhinney B; Whitby M
    Int J Antimicrob Agents; 2005 Jun; 25(6):514-22. PubMed ID: 15878264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ticarcillin/clavulanic acid treatment of gynecological infections.
    Gutschow K; Weissenbacher ER; Wachter I; Schneider A; Adam D; Götz A
    Acta Eur Fertil; 1987; 18(2):123-4. PubMed ID: 3630573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amoxicillin-potassium clavulanate, a beta-lactamase-resistant antibiotic combination.
    Stein GE; Gurwith MJ
    Clin Pharm; 1984; 3(6):591-9. PubMed ID: 6391783
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infections of the soft tissue.
    Timmes JJ
    Am J Med; 1985 Nov; 79(5B):134-5. PubMed ID: 4073080
    [No Abstract]   [Full Text] [Related]  

  • 28. Ticarcillin plus clavulanic acid in the treatment of patients with cancer.
    Fainstein V; Elting L; Pitlik S; Hortobagyi G; Keating M; Bodey GP
    Am J Med; 1985 Nov; 79(5B):62-6. PubMed ID: 4073096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic therapy for pelvic inflammatory disease.
    Pastorek JG
    J Reprod Med; 1990 Mar; 35(3 Suppl):329-32. PubMed ID: 2181120
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ticarcillin plus clavulanic acid in the treatment of pneumonia and other serious infections.
    Brittain DC; Scully BE; Neu HC
    Am J Med; 1985 Nov; 79(5B):81-3. PubMed ID: 4073099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
    Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of ticarcillin disodium plus clavulanate potassium in the management of acute bacterial infections in children.
    Gooch WM; Swenson E; Higbee MD
    Am J Med; 1985 Nov; 79(5B):184-7. PubMed ID: 4073089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
    Hou F; Li J; Gao L; Chen Y
    Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparative activity of ticarcillin-clavulanic acid and various beta-lactams against Pseudomonas maltophilia].
    Monteil H; Jehl F
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):805-8. PubMed ID: 3309818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials of extended spectrum penicillin/beta-lactamase inhibitors in the treatment of intra-abdominal infections. European and North American experience.
    Wilson SE; Nord CE
    Am J Surg; 1995 May; 169(5A Suppl):21S-26S. PubMed ID: 7755164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of Augpenin (clavulanic acid-ticarcillin) in urinary tract infections: especially against beta-lactamase producing strains].
    Shiono A; Kurihara J; Hayashi M; Suzuki T; Imai K; Yamanaka H; Takezawa Y; Kiren H; Okabe K; Tomaru Y
    Hinyokika Kiyo; 1993 Aug; 39(8):777-82. PubMed ID: 8379483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Beta-lactamase inhibitors].
    Gialdroni Grassi G
    G Ital Chemioter; 1982; 29(1):1-10. PubMed ID: 6764431
    [No Abstract]   [Full Text] [Related]  

  • 39. Ticarcillin disodium plus clavulanate potassium as initial therapy for hospitalized pediatric patients.
    Blumer JL
    Am J Med; 1985 Nov; 79(5B):192-3. PubMed ID: 4073091
    [No Abstract]   [Full Text] [Related]  

  • 40. Overview of bacterial infections of the skin and soft tissue and clinical experience with ticarcillin plus clavulanate potassium in their treatment.
    Pankey GA; Katner HP; Valainis GT; Clarkson MJ; Cortez LM; Dalovisio JR
    Am J Med; 1985 Nov; 79(5B):106-15. PubMed ID: 4073076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.